Another recent biotech IPO to come out of its quiet period today and buck the selling is...
Another recent biotech IPO to come out of its quiet period today and buck the selling is TetraPhase Pharmaceutical (TTPH +0.5%). A number of firms initiate coverage; Needham and Stifel Nicolaus start it with a Buy, BMO and JMP Securities with an Outperform, and Barclays with an Overweight. The stock has gained 15% since its March 13 debut.
From other sites
at Nasdaq.com (Feb 4, 2015)
at Benzinga.com (Dec 31, 2014)
at Benzinga.com (Dec 19, 2014)
at Investor's Business Daily (Dec 18, 2014)
at CNBC.com (Nov 24, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs